Amy Werkheiser

Director, Business Operations, Clinical Development Operations at Marinus Pharma

Amy Werkheiser has extensive work experience in the field of clinical development operations. Amy'smost recent role was as the Director of Business Operations at Marinus Pharma, where they were responsible for overseeing clinical development operations. Prior to that, they worked as an Associate Director at the same company.

Before joining Marinus Pharma, Amy served as a Senior Clinical Study Manager at BioCryst Pharmaceuticals, Inc. In this role, they were involved in managing clinical studies.

Amy has also worked at ICON plc, where they held positions as a Project Manager and a Senior Clinical Trial Manager. At ICON, they gained experience in project management and clinical trial oversight.

In addition, Amy has held roles at Zogenix, Inc. as a Clinical Study Manager, and at Premier Research as a Clinical Team Lead and a Clinical Manager. Amy also worked as an Independent Consultant at A. Frailey Research Consultants, LLC, where they provided research consulting services to pharmaceutical and device companies.

Earlier in their career, Amy worked at Endo International plc as a Senior Clinical Research Associate, managing multiple clinical trials and assisting in the submission of NDAs. Amy also served as a Clinical Research Associate at PharmaNet/i3 Strategic Resourcing and Covance. At Covance, they also worked as a Clinical Study Assistant.

Overall, Amy Werkheiser's work experience demonstrates their expertise in clinical development operations, project management, and clinical trial management.

Amy Werkheiser holds a Master's degree in Public Health from West Chester University of Pennsylvania. Prior to that, they earned a Bachelor's degree in Biology from Salisbury University.

Links

Previous companies

Premier Research logo
ICON logo
BioCryst Pharmaceuticals logo

Timeline

  • Director, Business Operations, Clinical Development Operations

    January, 2023 - present

  • Associate Director, Clinical Development Operations

    June, 2022

View in org chart